Abiopharma

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043691 <b>Size:</b> 643 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043692 <b>Size:</b> 758 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001193125-26-379897 <b>Size:</b> 661 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043690 <b>Size:</b> 585 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043689 <b>Size:</b> 582 KB

📋 Doyle John Q (Officer) plans to sell 17K shares of MARSH & MCLENNAN COMPANIES, INC. (at $188.51 each, total $3.1M) Filed: Sep 02, 2026 | ID: 006618

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043688 <b>Size:</b> 623 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043687 <b>Size:</b> 668 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043686 <b>Size:</b> 684 KB

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-09-02 <b>AccNo:</b> 0001839882-26-043685 <b>Size:</b> 663 KB